Videos

Educated Patient® MPN Summit Differentiating an Essential Thrombocythemia Diagnosis Presentation: May 7, 2022

May 22nd 2022

Watch Dr. Jamile Shammo, from Rush University Medical Center, discuss differentiating an essential thrombocythemia diagnosis, during the CURE Educated Patient MPN Summit.

Educated Patient® MPN Summit Focus on Clinical Trials Panel: May 7, 2022

May 21st 2022

Watch Dr. Jamile Shammo, Dr. Angela Fleishman and Kapila Viges answer questions about clinical trials during the CURE Educated Patient MPN Summit.

Enrolling in Clinical Trials for EGFR Exon 20–Positive NSCLC

May 20th 2022

A shared discussion on the importance of enrolling in clinical trials for EGFR exon 20–positive NSCLC and improving access to novel therapy for patients.

Educated Patient® MPN Summit Clinical Trials Presentation: May 7, 2022

May 20th 2022

Watch Kapila Viges, from the MPN Research Foundation, discuss clinical trials, during the CURE Educated Patient MPN Summit.

Improving Quality of Life While Receiving Treatment for NSCLC

May 20th 2022

A focused conversation on how a patient can maintain and improve quality of life while receiving therapy for non–small cell lung cancer.

Educated Patient® MPN Summit Novel Agents and Clinical Trials in Polycythemia Vera Presentation: May 7, 2022

May 19th 2022

Watch Dr. Angela Fleishman, from the University of California Irvine, discuss novel agents and clinical trials in polycythemia vera, during the CURE Educated Patient MPN Summit.

Educated Patient® MPN Summit Diagnoses and Treatment Panel: May 7, 2022

May 18th 2022

Watch Dr. Jamile Shammo, Dr. Aaron Gerds and Dr. Bart Scott, answer questions during the diagnoses and treatment panel during the CURE Educated Patient MPN Summit.

'There's a Gift in the Conflict' of Cancer, Says Patrick Dempsey

May 17th 2022

Actor and cancer advocate Patrick Dempsey explains that when a loved one is diagnosed with cancer, it is important that family members make the moments they share together count.

Educated Patient® MPN Summit Current Treatment Options Presentation: May 7, 2022

May 17th 2022

Watch Dr. Bart Scott, from Fred Hutchinson Cancer Center, discuss current treatment options, during the CURE Educated Patient MPN Summit.

A ‘Lighthouse Through the Cancer Storm’

May 16th 2022

A nurse navigator explains how people in their profession create bonds with their patients and guide them through the cancer experience.

Educated Patient® MPN Summit Approach to Diagnosing & Assessing Symptoms Presentation: May 7, 2022

May 16th 2022

Watch Dr. Aaron Gerds, from Cleveland Clinic Taussig Cancer Institute, discuss approaches to diagnosing and assessing symptoms, during the CURE Educated Patient MPN Summit.

Support for Patients Undergoing Treatment for NSCLC

May 13th 2022

Comprehensive discussion on support for patients receiving therapy for NSCLC, ranging from care team members to education materials to support groups.

How to Decide on Novel Therapy for EGFR Exon 20–Positive NSCLC

May 13th 2022

Looking at available novel therapy for EGFR exon 20 insertion–positive NSCLC, experts consider how patients can play a part in identifying their best treatment option.

Addressing Unmet Needs in Differentiated Thyroid Cancer

May 12th 2022

Before closing out their discussion on differentiated thyroid cancer, patients and health care professionals alike consider unmet needs in this space.

Educating Patients About Cancer Should Not Be a ‘One-Size-Fits-All’ Approach, Says Expert

May 11th 2022

When it comes to learning about their disease, patients with cancer can have different preferences, from wanting to discuss treatments with their providers or read handouts, while others may not want to know much at all.

Use of Amivantamab in patients with EGFR Exon 20–Positive Non–Small Cell Lung Cancer

May 6th 2022

An expert in the lung cancer and a representative from lung cancer advocacy group talk about the use of amivantamab, a novel therapy approved for treating EGFR exon 20 insertion–positive disease.

Access to Novel Therapy for EGFR Exon 20–Positive NSCLC

May 6th 2022

A brief discussion on the importance of accessing novel therapy and clinical trials in the setting of EGFR exon 20 insertion–positive NSCLC.

Patrick Dempsey Notes Mental Health in Cancer Care Has ‘Changed Tremendously’ Over Past 2 Decades

May 5th 2022

Mental wellbeing is more of a focus than ever before in cancer care, and while treatments continue to get better, there is still a long road ahead, according to Patrick Dempsey.

Unmet Needs and Future Perspectives in the Treatment of RCC

May 5th 2022

Bryan Lewis, president of KidneyCAN, and Chung-Han Lee, MD, describe unmet needs and future perspectives in the treatment of renal cell carcinoma.

The Importance of Patients Advocating for Themselves During Their RCC Journey

May 5th 2022

Meryl Uranga describes her path with metastatic clear cell renal cell carcinoma after first treatment, and how it has affected her outlook on her life and future.

Quality-of-Life with Systemic Therapies in Metastatic Clear Cell RCC

May 5th 2022

A look at how to consider quality-of-life clinical trial and patient-reported data when treating clear cell renal cell carcinoma with combination therapies.

Treating Radioiodine-Refractory DTC After Progression on Lenvatinib

May 5th 2022

A brief discussion on therapeutic options one may consider after progression on lenvatinib therapy for iodine-refractory DTC.

Practical Advice and Resources for Patients on Systemic Therapy for DTC

May 5th 2022

Shared practical advice for patients who may be undergoing treatment for iodine-refractory differentiated thyroid cancer.

Patient Experience with Systemic Therapy-Related Toxicities in Metastatic RCC

May 2nd 2022

Meryl Uranga describes her personal experience with managing the side effects of treatment for clear cell renal cell carcinoma.

Adverse Events Associated with IO-TKI Therapies in Metastatic Clear Cell RCC

May 2nd 2022

An overview of side effects commonly seen with lenvatinib plus pembrolizumab for the treatment of clear cell renal cell carcinoma.

Educated Patient® Kidney Cancer Summit Combination Therapy Panel: April 9, 2022

May 1st 2022

Watch Dr. Thomas Hutson, Dr. Saby George, Dr. Jeff Yorio and Louise Gunter answer questions about combination therapy, during the CURE Educated Patient Kidney Cancer Summit.

Educated Patient® Kidney Cancer Summit IO/TKI-Related Side Effects Presentation: April 9, 2022

April 30th 2022

Watch Louise Gunter, from Texas Oncology, discuss IO/TKI-related side effects, during the CURE Educated Patient Kidney Cancer Summit.

The Importance of Molecular Profiling and Patient Education in NSCLC

April 29th 2022

Shared insight on how molecular profiling can impact the management of EGFR exon 20 insertion–positive NSCLC and how patient advocacy groups can help patients to interpret test results.

Overview of EGFR Exon 20 and Molecular Testing in NSCLC

April 29th 2022

Experts explain the presence and role of EGFR exon 20 insertion mutations in non–small cell lung cancer and highlight the role of molecular profiling.

Educated Patient® Kidney Cancer Summit IO/TKI Therapies Presentation: April 9, 2022

April 29th 2022

Watch Dr. Jeff Yorio, from Texas Oncology, discuss treatment with the combination of immunotherapy and tyrosine kinase inhibitors, during the CURE Educated Patient Kidney Cancer Summit.